Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVISE-Diabesity: Endobarrier and Liraglutide in T2DM and Obesity
NCT02055014Phase 4Unknown
- Sponsor
- Sandwell and West Birmingham NHS Trust
- Start
- Jul 2013
- Primary completion
- Mar 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Sandwell and West Birmingham NHS Trust. Status: unknown.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02055014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02055014.